Multimodal Screening of Dry Eye Disease
NCT04235400 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2022-09-07
Summary
Two methods allow to evaluate tear breakup time (BUT): without prior dye instillation (No Dye BreakUp Time NDBUT) or after fluorescein instilation (FBUT). The interconnections between those two values are unknown
Conditions
Interventions
- DIAGNOSTIC_TEST
-
No Dye BreakUp Time
Measurement without dye of the tear meniscus height (TMH) which give an rapid hint on the quantity of tears present on the ocular surface, the measure in real time of the tear osmolarity and, at last, the analysis of the thickness of the tear's layer by interferometry (measurement of the light fringes reflected by the tears when illuminated with polarized light, whereby the complete layer or the lipid layer alone can be evaluated separately depending on the machines used) and of the assessment of the quality of the Meibomian glands (non-contact imaging by infrared illumination).
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Marc LABETOULLE, Pr · Assistance Publique - Hôpitaux de Paris
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-28
- Primary Completion
- 2023-01-31
- Completion
- 2023-03-31
Countries
- France
Study Locations
More Related Trials
-
Study of the TearCare System in Dry Eye Disease
NCT03588624 ·Status: COMPLETED ·Phase: NA
-
Microbiological Diagnosis of Infectious Keratitis to Pathogenic Fastidious Germs
NCT02819232 ·Status: COMPLETED ·Phase: NA
-
Correlation of Different Signs for Assessment of Dry Eye Syndrome
NCT01753687 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of FID 119515A
NCT01833117 ·Status: COMPLETED ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis of the Diagnostic Performance of LacryDiag, a New Analyzer of the Ocular Surface in the Dry Eye
NCT04093037 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of the InflammaDry Device for Detecting Dry Eye
NCT01692964 ·Status: COMPLETED
-
Dry Eye Evaluation System Based on Bioinformatics
NCT04109170 ·Status: UNKNOWN
-
A Natural History Study of Patients With Dry Eye
NCT00833235 ·Status: COMPLETED
-
Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT05888519 ·Status: COMPLETED ·Phase: NA
-
Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy Subjects
NCT01744457 ·Status: COMPLETED ·Phase: NA
-
Assessment of Inflammatory and Functional Changes in the Ocular Surface Associated With Dry Eye Disease
NCT00809003 ·Status: COMPLETED
-
Evaluation of Optical System in the Treatment of - Dry Eye Disease
NCT05741398 ·Status: UNKNOWN ·Phase: NA
-
Collection of Ocular Surface Impressions Cytology of the Living Eye From Patients With Dry Eyes or Limbal Stem Cell Deficiency.
NCT06255301 ·Status: COMPLETED
-
Moderate-to-Severe Dry Eye Disease Relief Using Acoltremon
NCT07268599 ·Status: ENROLLING_BY_INVITATION
-
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Diagnostics of Microbial Keratitis
NCT06364878 ·Status: RECRUITING
-
Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye
NCT03815539 ·Status: UNKNOWN ·Phase: NA
-
YM-101 Eye Drops in the Treatment of Dry Eye Syndrome
NCT06792903 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
HU007 Eye Drops in Patients With Dry Eye Syndrome
NCT04384991 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Evaporimetry With the Established Methods of Tear Film Measurement
NCT01496482 ·Status: COMPLETED
-
OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
NCT05814757 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Mu-Drop System for Serum Eye Drops
NCT03539159 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye Disease
NCT01753596 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
NCT05865457 ·Status: RECRUITING ·Phase: NA